The pattern we seen ultimately yr’s CES continues: Startups are really curious about your bodily fluids. Vivoo isn’t any exception. The corporate already presents a broad vary of at-home assessments, and launched a brand new check that may detect urinary tract infections (UTIs).
Vivoo’s At-Residence UTI Take a look at streamlines the diagnostic course of for UTIs, which have an effect on an astonishing 150 million folks globally annually. The corporate harnesses the ability your cellphone’s digicam to document and analyze the colour readout of the check strips. It then provides recommendation and context for the readings in its free app.
For ladies, who signify 60% of UTI victims in the US, Vivoo’s product could show to be a game-changer. Folks usually assume they’ve an UTI, however can’t be bothered going to the physician with it. Having the ability to check at residence shortcuts the method, and the app delivers free instructional content material, additional supporting their mission to democratize healthcare information.
Vivoo has a quickly rising variety of assessments, and claims to have greater than 200,000 customers worldwide thus far. Picture credit score: TechCrunch / Haje Kamps
Vivoo’s journey in reworking private well being administration started with the launch of its ‘smart toilet’ at CES final yr, which obtained accolades for its function in early well being situation detection.
With a consumer base exceeding 200,000 and a rising portfolio of at-home assessments, together with wellness indicators like hydration and vitamin ranges, Vivoo’s partnership with Goal and its world distribution community is about to make personalised well being administration a actuality for tens of millions worldwide.
